This attack does 30 more damage for each Colorless in your opponent's Active Pokémon's Retreat Cost.
Turn all of your Prize cards face up. (Those Prize cards remain face up for the rest of the game.) (You can't use more than 1 GX attack in a game.)
Ultra Prism was released in 2018. Series classification for this set is Sun & Moon.
With 178 listed cards, this is a large set by modern TCG standards. As of 2026, the set is 8 years old and now falls into an established back-catalog period.
In the Ultra Prism checklist, Celesteela-GX occupies position #144 as a Rare Ultra card.
Celesteela-GX is a Ultra Prism card from the 2018 release window. Its card type is Pokémon.
The rarity label is Rare Ultra. Printed HP is 200.
Energy typing is Metal. This gives collectors a clear identity footprint for the print.
It carries a Basic, GX, and Ultra Beast subtype designation. Printed card effect: Pokémon-GX rule: When your Pokémon-GX is Knocked Out, your opponent takes 2 Prize cards.
Current market pricing for Celesteela-GX (Ultra Prism) sits near $9.41. Price action is stable over 7 days, moving only 0.0%.
That is close to the 30-day average of $9.43. The 90-day window shows a floor near $9.35 and a peak around $10.55 (13% total spread), which maps to low-volatility movement.
The listed rarity for this print is Rare Ultra.
Celesteela-GX sits within a broader pool of Celesteela-GX variants that can be compared by set, rarity, and price. The current sample spans 5 comparable cards from 3 sets.
Observed alternatives run from $2.80 to $35.08 (1153% spread). The current card sits -17% versus the sampled alternative average of $11.39.
Notable alternatives include Celesteela-GX #SM67 (SM Black Star Promos) at $5.70, Celesteela-GX #162 (Ultra Prism) at $35.08, Celesteela-GX #163 (Unbroken Bonds) at $2.80, and Celesteela-GX #228 (Unbroken Bonds) at $8.47.
Pricing context for collectors: Weekly drift is minimal (0.0%), indicating a relatively balanced short-term market. The 90-day range spans $9.35 to $10.55 (13% spread), which indicates low-volatility behavior.
Relative to the 30-day baseline ($9.43), pricing is near equilibrium. Condition sensitivity is substantial: PSA 10 carries a +325% premium over raw value.
PSA 9 is currently around $19.52, while PSA 10 is $39.96.
